1. Home
  2. KRNT vs ENGN Comparison

KRNT vs ENGN Comparison

Compare KRNT & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kornit Digital Ltd.

KRNT

Kornit Digital Ltd.

HOLD

Current Price

$13.86

Market Cap

695.1M

Sector

Industrials

ML Signal

HOLD

Logo enGene Holdings Inc.

ENGN

enGene Holdings Inc.

HOLD

Current Price

$11.28

Market Cap

605.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRNT
ENGN
Founded
2002
1999
Country
Israel
Canada
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
695.1M
605.5M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
KRNT
ENGN
Price
$13.86
$11.28
Analyst Decision
Buy
Buy
Analyst Count
4
7
Target Price
$19.75
$22.71
AVG Volume (30 Days)
290.8K
328.0K
Earning Date
02-11-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$210,041,000.00
N/A
Revenue This Year
$3.86
N/A
Revenue Next Year
$2.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.17
N/A
52 Week Low
$11.93
$2.65
52 Week High
$31.24
$11.14

Technical Indicators

Market Signals
Indicator
KRNT
ENGN
Relative Strength Index (RSI) 41.92 73.19
Support Level $13.64 $8.68
Resistance Level $14.65 $9.20
Average True Range (ATR) 0.51 0.74
MACD -0.12 0.21
Stochastic Oscillator 9.73 97.54

Price Performance

Historical Comparison
KRNT
ENGN

About KRNT Kornit Digital Ltd.

Kornit Digital Ltd develops, designs and markets digital printing solutions for the world-wide printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software and value-added services that allow for large-scale printing of short runs of complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink and other consumables and service including software subscriptions The company geographically operates in U.S., EMEA, Asia Pacific and other countries. It derives maximum revenue from U.S.

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Share on Social Networks: